Article
A Novel MALT1-related Immune Prognostic Signature and Targeted Drug Screening for Glioblastoma
2023-05-08
Abstract excerpt
As the most common intracranial malignancy in adults, glioblastoma (GBM) has limited improvement in prognosis with traditional treatment methods, such as surgery, chemotherapy, and radiotherapy. Currently, immunotherapy has revolutionized treatment outcomes for many cancers. However, special immunosuppressive microenvironment of GBM results in patients’ resistance to immunotherapy and poor prognosis. The mucosa-as...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b5b5db7f-1c94-5ae8-85f0-650205209e3c
- DOI
- 10.21203/rs.3.rs-2866606/v1